AAT

BIOLOGICAL2 trials

Sponsors

Rabin Medical Center, CSL Behring

Conditions

Acute-graft-versus-host DiseaseBronchiolitis Obliterable SyndromeLung Transplantation

Phase 2

Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients

Rabin Medical CenterBronchiolitis Obliterable Syndrome, Lung Transplantation

Start: 2011-09-30End: 2013-09-30Target: 40Updated: 2011-07-14

The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant

TerminatedNCT03805789

CSL BehringAcute-graft-versus-host Disease

Start: 2019-03-27End: 2026-03-19Updated: 2026-09-09

Related Papers

Altered Serum Alpha1-Antitrypsin Protease Inhibition before and after Clinical Hematopoietic Stem Cell Transplantation: Association with Risk for Non-Relapse Mortality

International Journal of Molecular Sciences2023-12-283 citations